Digital therapeutics: Software is now entering mainstream therapeutic care
The news that a prominent insurer had decided to cover a digital therapeutic for opioid disorder spurred national headlines recently. In this case, the therapeutic had a breakthrough designation from the FDA. That payer decision underscored the potential as well as the challenges that have arisen around developing and marketing digital therapeutics, which have become a fast-growing segment within digital healthcare. DTx delivers clinical interventions directly to patients via software to treat, manage or prevent disease – ranging from behavioral health conditions to diabetes. We’ll take a close look at this burgeoning field and see where we’re headed in the years to come.
Click here to find additional details and registration information.
